What is BNTC's relative strength rating?

BNTC ranks at the 72th percentile over 1 month, 72th percentile over 3 months, 72th percentile over 6 months, 45th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is BNTC in?

BNTC is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is BNTC in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). BNTC benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is BNTC?

BNTC currently shows a 20-day average daily range (ADR%) of 6.7%, a 90-day beta versus the S&P 500 of 1.20. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does BNTC have a seasonal pattern?

TickerStance computes BNTC's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what BNTC has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did BNTC last report earnings?

BNTC most recently filed a 10-Q covering FY26 Q3 with the SEC on 2026-05-14. TickerStance sources earnings data from SEC EDGAR XBRL submissions and updates the fundamentals panel daily. The Pro dossier shows eight quarters of EPS and revenue trend, operating margin history, and a composite earnings-quality rank.

Benitec Biopharma Inc. Common Stock (BNTC) · RS 72

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Benitec Biopharma Inc. Common Stock (BNTC) has a 3-month relative strength percentile of 72 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.7%, relative volume 0.70×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month72pctile

6 month72pctile

1 year45pctile

Classic54IBD pctile

LDR67leadership

0 of 5 lenses lit · avg RS pctile 62

✓ADR%6.7%!A/DE!RVOL0.70×!$ Vol$2M

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2022

Best monthFeb on averageavg +25.79% · 75% win · n 4

Worst monthSep on averageavg -10.49% · 50% win · n 4

BNTC monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	BNTC Jan avg: 0.92% median: -9.30% win: 25% σ: 22.98% n: 4 2022-04-12 → 2026-07-31	BNTC Feb avg: 25.79% median: 20.53% win: 75% σ: 35.40% n: 4 2022-04-12 → 2026-07-31	BNTC Mar avg: -5.43% median: 0.03% win: 50% σ: 16.96% n: 4 2022-04-12 → 2026-07-31	BNTC Apr avg: 9.87% median: 4.46% win: 60% σ: 31.87% n: 5 2022-04-12 → 2026-07-31	BNTC May avg: -2.12% median: -4.07% win: 40% σ: 19.68% n: 5 2022-04-12 → 2026-07-31	BNTC Jun avg: -1.46% median: -1.08% win: 40% σ: 15.73% n: 5 2022-04-12 → 2026-07-31	BNTC Jul avg: -8.46% median: -12.48% win: 20% σ: 19.17% n: 5 2022-04-12 → 2026-07-31	BNTC Aug avg: 1.61% median: 1.52% win: 50% σ: 16.54% n: 4 2022-04-12 → 2026-07-31 (current)	BNTC Sep avg: -10.49% median: 0.92% win: 50% σ: 26.31% n: 4 2022-04-12 → 2026-07-31	BNTC Oct avg: -0.60% median: 15.48% win: 75% σ: 34.89% n: 4 2022-04-12 → 2026-07-31	BNTC Nov avg: -4.94% median: -7.95% win: 25% σ: 16.12% n: 4 2022-04-12 → 2026-07-31	BNTC Dec avg: 3.40% median: 2.75% win: 75% σ: 17.29% n: 4 2022-04-12 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

3 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

72

3m

72

6m

72

1y

45

LDR

—

StageWeinstein stage analysis

Stage 1 · Basing

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · BNTC

Does the business back the chart?

SEC EDGAR · last filing 10-Q · FY26 Q3 · period end 2026-03-31 · Latest filing 103 days old — may be pre-earnings

27

Fundamentals Growth Rank

How does growth rank vs. the universe?

vs. 4,480 ranked stocks · Sector rank 31

View fundamental leadership map

Laggard

Earnings

Are losses narrowing?

Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.

Loss flat

−$2.64—

23 Q4

−$0.18—

24 Q3

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
BNTC
72RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

ABUSArbutus Biopharma Corporation Common Stock71 NVONovo-Nordisk A/S71 EQEquillium, Inc. Common Stock72 XLOXilio Therapeutics, Inc. Common Stock72

ETF OWNERS

ETFs holding BNTC

BNTC is held by 10 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $2M.

Held by 18 ETFs · $25M across latest filings · largest weight 2.58% (PINK).

ETFs holding: 10
Total value: $2M
Top 3 concentration: 92.3%
Max weight: GNOM · 0.38%

Top 10 by value, from SEC N-PORT-P filings dated May 2026.

ETFs holding BNTC ranked by value
ETF	Weight	Value	Δ
VTWO	0.01%	$1M	—
GNOM	0.38%	$212K	new
VTWG	0.01%	$208K	—
GSSC	0.01%	$89K	—
VTHRVanguard Russell 3000 ETF	0.00%	$14K	—
ITWO

Public attention · BNTC

Is the crowd watching?

38/ 100 · vs its own 90-day norm▼ 9 vs 7dStealth leader

Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Float21.1Mshares

Shares out34.4Mshares

Market cap$436.6MSmall Cap

FAQ

Frequently asked questions

What is BNTC's relative strength rating?: BNTC ranks at the 72th percentile over 1 month, 72th percentile over 3 months, 72th percentile over 6 months, 45th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is BNTC in?: BNTC is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is BNTC in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). BNTC benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is BNTC?: BNTC currently shows a 20-day average daily range (ADR%) of 6.7%, a 90-day beta versus the S&P 500 of 1.20. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does BNTC have a seasonal pattern?: TickerStance computes BNTC's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what BNTC has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Benitec Biopharma Inc. Common Stock (BNTC) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding BNTC

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?

§ Seasonality

Benitec Biopharma Inc. Common Stock (BNTC) — Stance & relative strength

BNTC is on the watchlist, not confirmed. 3m RS is 72, Market Stance is mixed at 47.8, A/D rating E

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Are losses narrowing?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

ETFs holding BNTC

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

Is revenue confirming?

Are margins expanding?

Share count: tailwind or headwind?